ReviewJournal of hematology & oncology2015
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.
Shundong Cang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
165 papers cite itlatest 60 shown
this paperpooled itcites it